Quality Control and Quality Assurance (QA and QC)

Articles

What does FDA oversight mean for cannabis businesses and the industry as a whole?

The FDA is Coming…Will the Cannabis Industry Be Ready? Part I

Suggestions on how to deal with the problem of inter-laboratory error in the cannabis industry.

The Pet Lab Syndrome

Highlights of the challenges facing the cannabis extracts industry and discussion about the need for standardized methods and the role of laboratory accreditation.

Cannabis Extracts: The Need for Standardization and Accreditation in Emerging Industries

An argument for moving away from traditional culture-based methods and towards employing methods with increased specificity and accuracy.

Budtender: Is That a Harmful Mold in My Bud?

 is a Princeton, New Jersey-based psychiatrist, writer, speaker, educator, and consultant. He is the founder and board president of Doctors for Cannabis Regulation. Dr. Nathan is a Distinguished Fellow of the American Psychiatric Association and Clinical Associate Professor of Psychiatry at Rutgers Robert Wood Johnson Medical School. He serves on the editorial board of 

This article proposes cannabis labeling standards to serve as a foundation for the regulation of cannabis product packaging for both medical and adult-use products.

Setting the Standard for Cannabis Labeling: Introducing the Universal Cannabis Product Symbol and the Universal Cannabis Information Label

Here we examine the history of cannabis in the US, the role the USP played in that field, and the new role the USP is taking with cannabis for medical use.

Everything Old is New Again: Cannabis Returns to USP

John S. Abrams, PhD, discusses some of the cutting-edge work he’s involved in and what he’s looking forward to at this year's Emerald Conference.

The Science Behind the Emerald Conference

This tutorial article outlines some of the steps that cannabis testing laboratories can take to prepare ahead of a third-party safety audit.

Five Steps to Prepare Cannabis Testing Laboratories for ISO 17025 Audits

is an Application Scientists with Agilent Technologies in Wilmington, Delaware.

is a Senior Scientist at Agilent Technologies and a Visiting Professor at The Johns Hopkins University School of Medicine in Baltimore, Maryland.

In this study, six different brands of CBD oil pet supplements were obtained and untargeted analyses using gas phase-time of flight mass spectrometry were performed.

GC-TOF Discovery-Based Profiling of CBD Oil Pet Supplements 

This article covers the importance of quality control, how to implement it, and what cannabis cultivators, processors, retailers, and consumers should look for on laboratory reports and certificates of analysis.